Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ka Kit Wong

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
The British Journal of Radiology|October 26, 2018
The utility of bone scintigraphy with SPECT/CT in the evaluation and management of frostbite injuriesMatthew S Manganaro, John D Millet, Richard Kj Brown, et al.
Clinical Nuclear Medicine|April 3, 2023
177Lu-DOTATATE Theranostics: Predicting Renal Dosimetry From Pretherapy 68Ga-DOTATATE PET and Clinical BiomarkersAvery B Peterson, Chang Wang, Ka Kit Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
Multicycle Dosimetric Behavior and Dose-Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide TherapyGunjan Kayal, Molly E Roseland, Chang Wang, et al.
Endocrine|October 3, 2014
Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literatureAsha Kandathil, Ka Kit Wong, Daniel J Wale, et al.
AJR. American Journal of Roentgenology|November 27, 2018
Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma?Laura K Sedig, Jason J Bailey, Ka Kit Wong, et al.
Nuclear Medicine Communications|March 17, 2012
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticalsKa Kit Wong, Amanda M Laird, Amir Moubayed, et al.
Nuclear Medicine Communications|June 15, 2022
Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumorsKa Kit Wong, Kirk A Frey, Jeremy Niedbala, et al.
Radiology|March 21, 2018
Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST CriteriaBenjamin L Viglianti, Daniel J Wale, Ka Kit Wong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2023
The predictive value of pretherapy [<sup>68</sup>Ga]Ga-DOTA-TATE PET and biomarkers in [<sup>177</sup>Lu]Lu-PRRT tumor dosimetryAzadeh Akhavanallaf, Avery B Peterson, Kellen Fitzpatrick, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2016
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applicationsGianpiero Manca, Eleonora Vanzi, Domenico Rubello, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The British Journal of Radiology|October 26, 2018
The utility of bone scintigraphy with SPECT/CT in the evaluation and management of frostbite injuriesMatthew S Manganaro, John D Millet, Richard Kj Brown, et al.
Clinical Nuclear Medicine|April 3, 2023
177Lu-DOTATATE Theranostics: Predicting Renal Dosimetry From Pretherapy 68Ga-DOTATATE PET and Clinical BiomarkersAvery B Peterson, Chang Wang, Ka Kit Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
Multicycle Dosimetric Behavior and Dose-Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide TherapyGunjan Kayal, Molly E Roseland, Chang Wang, et al.
Endocrine|October 3, 2014
Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literatureAsha Kandathil, Ka Kit Wong, Daniel J Wale, et al.
AJR. American Journal of Roentgenology|November 27, 2018
Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma?Laura K Sedig, Jason J Bailey, Ka Kit Wong, et al.
Nuclear Medicine Communications|March 17, 2012
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticalsKa Kit Wong, Amanda M Laird, Amir Moubayed, et al.
Nuclear Medicine Communications|June 15, 2022
Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumorsKa Kit Wong, Kirk A Frey, Jeremy Niedbala, et al.
Radiology|March 21, 2018
Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST CriteriaBenjamin L Viglianti, Daniel J Wale, Ka Kit Wong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2023
The predictive value of pretherapy [<sup>68</sup>Ga]Ga-DOTA-TATE PET and biomarkers in [<sup>177</sup>Lu]Lu-PRRT tumor dosimetryAzadeh Akhavanallaf, Avery B Peterson, Kellen Fitzpatrick, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2016
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applicationsGianpiero Manca, Eleonora Vanzi, Domenico Rubello, et al.
Pageof 11